Get started
Author

Pelin Arabacilar Golforoush

Observed names: P. Golforoush, Pelin A. Golforoush, Pelin Arabacilar, Pelin Golforoush
Observed institutions: St Thomas' Hospital, King's College London, GlaxoSmithKline (United Kingdom), The Francis Crick Institute, British Heart Foundation, GlaxoSmithKline (United States), St. Thomas Hospital, University College London, Imperial College London
ORCID: 0000-0002-7543-4167
Observed ORCID: 0000-0002-7543-4167
OpenAlex ID: A5014887889
Mouse models of atherosclerosis and their suitability for the study of myocardial infarction
2020 · Pelin Golforoush, Derek M. Yellon, et al. · Basic Research in Cardiology · 123
PDF
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo
2019 · Lorna R. Fiedler, Kathryn Chapman, et al. · Cell stem cell · 103
PDF
The case for inhibiting p38 mitogen-activated protein kinase in heart failure
2015 · Pelin Arabacilar, Michael Marber · Frontiers in Pharmacology · 62
PDF
Advancements in risk stratification and management strategies in primary cardiovascular prevention
2024 · Fotios Barkas, Yusuf Ziya Sener, et al. · Atherosclerosis · 58
Remote ischaemic conditioning: defining critical criteria for success—report from the 11th Hatter Cardiovascular Workshop
2022 · R. M. Bell, M. Basalay, et al. · Basic Research in Cardiology · 52
PDF
Activation of the Amino Acid Response Pathway Blunts the Effects of Cardiac Stress
2017 · Pu Qin, Pelin Arabacilar, et al. · Journal of the American Heart Association · 30
Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4
2020 · Pelin A. Golforoush, Priyanka Narasimhan, et al. · Scientific Reports · 28
PDF
The TAB1-p38α complex aggravates myocardial injury and can be targeted by small molecules
2018 · Gian F. De Nicola, Rekha Bassi, et al. · JCI Insight · 25
PDF
p38γ MAPK contributes to left ventricular remodeling after pathologic stress and disinhibits calpain through phosphorylation of calpastatin
2019 · Aminah A. Loonat, E. Denise Martin, et al. · The FASEB Journal · 22
PDF
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo
2020 · Lorna R. Fiedler, Kathryn Chapman, et al. · Cell stem cell · 14
PDF
Inter-organ communication: pathways and targets to cardioprotection and neuro-protection. A report from the 12th Hatter Cardiovascular Institute workshop
2024 · L. Pearce, C. Galán-Arriola, et al. · Basic Research in Cardiology · 13
PDF
Investigating the cause of cardiovascular dysfunction in chronic kidney disease: capillary rarefaction and inflammation may contribute to detrimental cardiovascular outcomes
2024 · Siavash Beikoghli Kalkhoran, Maryna Basalay, et al. · Basic Research in Cardiology · 11
PDF
Intensive care for human hearts in pluripotent stem cell models
2020 · Pelin Golforoush, Michael D. Schneider · npj Regenerative Medicine · 9
PDF
An activator of phosphatidylinositol 3-kinase alpha restores cardioprotection from ischaemia/reperfusion injury in mice with coronary atherosclerosis or insulin resistance
2025 · Pelin Golforoush, Elias Sulaiman, et al. · Cardiovascular Research · 5
PDF
RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
2021 · Sean M. Davidson, Kishal Lukhna, et al. · Cardiovascular Drugs and Therapy · 3
PDF
Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial
2022 · Kishal Lukhna, Helison R. P. do Carmo, et al. · Cardiovascular Drugs and Therapy · 2
PDF
BS11 Optimising the adenine-induced rat model of chronic kidney disease to investigate the mechanism of cardiorenal disease
2024 · Siavash Beikoghli Kalkhoran, Maryna Basalay, et al. · 1
Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
2021 · Sean M. Davidson, Kishal Lukhna, et al. · Cardiovascular Drugs and Therapy · 1
PDF
Features of Lipid Disorders in Cardiovascular–Kidney–Metabolic Syndrome
2026 · Alexandr Ceasovschih, Yusuf Ziya Şener, et al. · International Journal of Molecular Sciences
Experimental sepsis causes SERCA2 expression in white adipose tissue but not classical browning
2026 · Robert Tidswell, Ali Alqallaf, et al. · Scientific Reports
PDF
Cardioprotection from ischemia/reperfusion injury is impaired in mice with coronary atherosclerosis or insulin resistance, but this is overcome by a direct chemical activator of PI3Kalpha
2025 · Pelin Golforoush, David He, et al. · Atherosclerosis
PDF
Predictive markers for aortic atheromatosis and mitral annular calcification in type 2 diabetes patients without established cardiovascular disease
2024 · Elena-Daniela Grigorescu, Cristina-Mihaela Lacatusu, et al. · Atherosclerosis
PDF
Investigating cardiac changes caused by coronary atherosclerosis using SRBI/LDLR KO mice
2023 · P. Golforoush · Atherosclerosis
Investigating the mechanisms of p38 activation
2016 · Pelin Arabacilar · Research Portal (King's College London)
Abstract 336: TAB1 Initiates p38α Autophosphorylation During Myocardial Ischemia
2012 · Rekha Bassi, Pelin Arabacilar, et al. · Circulation Research
Works count: 27
Citation count: 561
H-index: 11
I10-index: 12
Year
Topic
Type